Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma

Tumor Biology

Volumn 37, Issue 7, 2016, Pages 8621-8631

  Dai, Bin ^a   Zhang, Yisong ^a   Zhang, Peng ^a   Pan, Changcun ^a   Xu, Cheng ^a   Wan, Weiqing ^a   Wu, Zhen ^a   Zhang, Junting ^a   Zhang, Liwei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

FAT10; Glioma; Proliferation; Smad2

Indexed keywords

LEUKOCYTE ANTIGEN F ASSOCIATED TRANSCRIPT 10; SMAD2 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; MESSENGER RNA; SMAD2 PROTEIN, HUMAN; TUMOR MARKER; UBD PROTEIN, HUMAN; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CANCER PATIENT; CANCER PROGNOSIS; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FAT10 GENE; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; P SMAD2 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; BRAIN TUMOR; CANCER STAGING; CASE CONTROL STUDY; CELL MOTION; COMPARATIVE STUDY; DRUG SCREENING; ENZYME IMMUNOASSAY; FOLLOW UP; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; PHOSPHORYLATION; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR INVASION; WOUND HEALING;

ANIMALS; APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; FOLLOW-UP STUDIES; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHOSPHORYLATION; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD2 PROTEIN; SURVIVAL RATE; TUMOR CELLS, CULTURED; UBIQUITINS; WOUND HEALING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84953332302     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4739-6     Document Type: Article

References (21)

1. Butowski NA, Sneed PK, Chang SM. Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol. 2006;24(8):1273–80.
2. Kaminska B, Kocyk M, Kijewska M. TGF beta signaling and its role in glioma pathogenesis. Adv Exp Med Biol. 2013;986:171–87.
3. Swiatek-Machado K, Kaminska B. STAT signaling in glioma cells. Adv Exp Med Biol. 2013;986:189–208.
4. Gong A, Huang S. FoxM1 and Wnt/beta-catenin signaling in glioma stem cells. Cancer Res. 2012;72(22):5658–62.
5. Zhang X, Chen T, Zhang J, Mao Q, Li S, Xiong W, et al. Notch1 promotes glioma cell migration and invasion by stimulating beta-catenin and NF-kappaB signaling via AKT activation. Cancer Sci. 2012;103(2):181–90.
6. Isaacson MK, Ploegh HL. Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell Host Microbe. 2009;5(6):559–70.
7. Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G. FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol Cell Biol. 2005;25(9):3483–91.
8. Buchsbaum S, Bercovich B, Ciechanover A. FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination. Mol Biol Cell. 2012;23(1):225–32.
9. Ren J, Kan A, Leong SH, Ooi LL, Jeang KT, Chong SS, et al. FAT10 plays a role in the regulation of chromosomal stability. J Biol Chem. 2006;281(16):11413–21.
10. Li T, Santockyte R, Yu S, Shen RF, Tekle E, Lee CG, et al. FAT10 modifies p53 and upregulates its transcriptional activity. Arch Biochem Biophys. 2011;509(2):164–9.
11. Ji F, Jin X, Jiao CH, Xu QW, Wang ZW, Chen YL. FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging. World J Gastroenterol. 2009;15(18):2228–33.
12. Yuan J, Tu Y, Mao X, He S, Wang L, Fu G, et al. Increased expression of FAT10 is correlated with progression and prognosis of human glioma. Pathol Oncol Res. 2012;18(4):833–9.
13. Liu L, Dong Z, Liang J, Cao C, Sun J, Ding Y, et al. As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3beta pathway. Oncogene. 2014;33(7):909–20.
14. Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang P, et al. CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression. Cancer Res. 2014;74(2):520–31.
15. Sun Y, Wang Y, Fan C, Gao P, Wang X, Wei G, et al. Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation. Mol Cancer. 2014;13:137.
16. Theng SS, Wang W, Mah WC, Chan C, Zhuo J, Gao Y, et al. Disruption of FAT10-MAD2 binding inhibits tumor progression. Proc Natl Acad Sci U S A. 2014;111(49):E5282–91.
17. Yuan R, Wang K, Hu J, Yan C, Li M, Yu X, et al. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying beta-catenin degradation. Cancer Res. 2014;74(18):5287–300.
18. Lukasiak S, Schiller C, Oehlschlaeger P, Schmidtke G, Krause P, Legler DF, et al. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene. 2008;27(46):6068–74.
19. Canaan A, DeFuria J, Perelman E, Schultz V, Seay M, Tuck D, et al. Extended lifespan and reduced adiposity in mice lacking the FAT10 gene. Proc Natl Acad Sci U S A. 2014;111(14):5313–8.
20. Liang X, Zeng J, Wang L, Shen L, Ma X, Li S, et al. Histone demethylase RBP2 promotes malignant progression of gastric cancer through TGF-beta1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit. Oncotarget. 2015;6(19):17661–74.
21. Jennings MT, Pietenpol JA. The role of transforming growth factor beta in glioma progression. J Neurooncol. 1998;36(2):123–40.